Washington, D.C. – March 30, 2026 — Revival Research Institute will participate in the upcoming World Vaccine Congress Washington, taking place March 30 – April 2, 2026, at the Walter E. Washington Convention Center. The congress is recognized as one of the leading global events dedicated to vaccines, bringing together biotech innovators, vaccine developers, pharmaceutical sponsors, CROs, and clinical research organizations to explore the future of vaccine development.
The event provides a platform for professionals across the vaccine ecosystem to exchange ideas, share research insights, and discuss the evolving landscape of vaccine science and clinical trials. Beyond scientific sessions, the congress encourages conversations around clinical operations, research strategies, and the challenges involved in advancing vaccine studies from development to patient access.
Revival Research Institute will join fellow industry leaders to engage in discussions focused on improving trial efficiency, applying real-world insights, and leveraging data-driven strategies that strengthen clinical research outcomes.
Speaker Spotlight: Mazhar Jaffry
During the session, Mazhar Jaffry will discuss how integrating real-world data with advanced analytics can strengthen clinical trial performance. As vaccine studies become more complex, research teams are increasingly seeking innovative ways to better understand recruitment patterns, operational trends, and site-level performance metrics.
The presentation will highlight how data-driven insights can help identify operational challenges, optimize enrollment strategies, and improve overall trial efficiency. Leveraging predictive analytics and real-world insights allows research teams and sponsors to make informed decisions throughout the clinical development process, supporting faster and more reliable study outcomes.
Strengthening Collaboration in Vaccine Research
Taking part in World Vaccine Congress Washington underscores Revival Research Institute’s commitment to engaging with the broader global clinical research community. The event serves as a platform where professionals can exchange insights, develop new partnerships, and discuss emerging solutions that support the future of vaccine development.
As the congress approaches, the Revival team looks forward to connecting with colleagues, partners, and innovators from across the industry. Conferences like these often spark meaningful conversations that lead to new ideas and collaborations that shape the future of clinical research.
About Revival Research Institute
Revival Research Institute is a clinical research organization dedicated to advancing healthcare through innovative and patient-centered clinical trials. With accredited research sites across the United States, the organization has conducted more than 500 Phase I–IV studies across therapeutic areas including cardiology, dermatology, nephrology, psychiatry, and women’s health. Revival partners with sponsors to deliver high-quality clinical trial execution while ensuring research participants are treated with dignity, safety, and care.
